3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Oligodendroglioma
1
Gliosarcoma
1
Glioblastoma
1
Ependymoma
1
Astrocytoma
1
Interventions
Temozolomide
16
Magnetic Resonance Spectroscopy
10
Etoposide
9
Cyclophosphamide
8
Radiotherapy
7
Carboplatin
7
Bevacizumab
7
Filgrastim
6
Thiotepa
5
Radiation
4
Biopsy
4
Azacitidine
4
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
4
sargramostim
3
etoposide phosphate
3
Surveys and Questionnaires
3
Peripheral Blood Stem Cell Transplantation
3
Nivolumab
3
Methotrexate
3
Irinotecan
3
Gadolinium DTPA
3
Cisplatin
3
Automobiles
3
lutetium Lu 177 dotatate
2
fluorodopa F 18
2
alovudine
2
aldesleukin
2
Yoga
2
Topotecan
2
Thalidomide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Ependymoma
×
picropodophyllin
×
Clear all
NCT01721577
2023-05-22
AXL1717
Rush University Medical Center
Phase 1/2
Terminated
10 enrolled
8 charts